At the Intersection of Science and Engineering: Novel Platform Approach to Immunotherapy with IGM-2323

ESMO Immuno-Oncology Virtual Congress 2020 – December 9-12, 2020
Educational Session: Novel Immunotherapeutic Platforms – December 11, 2020

Daniel S. Chen, MD, PhD, Chief Medical Officer
IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

ESMO IO 2020 DSChen

Posted in publications.